Braster S.A. Stock

BRA

PLBRSTR00014

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 11:55:52 2025-11-27 EST			5-day change	1st Jan Change
0.5800 ^PLN	-.--%		+0.58%	-

24-05-29	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
23-11-29	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Braster SA w restrukturyzacji, formerly Braster SA, is a Poland-based company principally engaged in the bio diagnostics and testing. The Company provides research and development on breast cancer. It applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The Company cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.

Employees

Sector

Biotechnology & Medical Research

More about the company

Income Statement and Estimates

More financial data

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	17.04M 4.57M 3.96M 3.71M 3.38M 6.37M 436M 6.48M 43.5M 218M 17.17M 16.79M 728M	P/E 2022	-5.18x	P/E 2023	-3.55x
Enterprise Value	28.34M 7.6M 6.59M 6.17M 5.63M 10.59M 725M 10.77M 72.34M 363M 28.55M 27.93M 1.21B	EV / Sales 2022	15.4x	EV / Sales 2023	88.9x
Free-Float	80.79%	Yield 2022 *	-	Yield 2023	-

24-05-29	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
23-11-29	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-10-03	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-05-24	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-05-02	Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-05-02	Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
22-11-21	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
22-09-27	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	CI
22-05-24	Braster S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
22-05-02	Braster S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
21-11-29	Braster S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
21-09-30	Braster S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	CI
21-09-22	An unknown buyer acquired 21.38% stake in Braster S.A. from Carom Sp. z o.o.	CI

5 years	0.53		1.52
10 years	0.19		30

Director	Title	Age	Since
Katarzyna Kilijanczyk BRD	Director/Board Member	-	-
Elzbieta Kozik BRD	Director/Board Member	-	-
Zygfryd Kosidowski BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BRASTER S.A.	-.--%	+0.58%	-	-	4.61M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-0.24%	+3.42%	+108.97%	+303.02%	4.05B
VERACYTE, INC.	+0.30%	0.00%	+65.81%	+84.53%	3.73B
IOVANCE BIOTHERAPEUTICS, INC.	+1.41%	+48.85%	+229.44%	-8.07%	2.94B
CAREDX, INC.	+0.34%	+0.30%	+301.27%	+430.67%	2.44B
BGI GENOMICS CO., LTD.	+1.43%	+5.85%	-22.03%	-29.93%	2.35B
FREENOME, INC.	+4.22%	+6.51%	+9.93%	-	1.35B
SEEGENE, INC.	+5.85%	+16.46%	+17.72%	+46.95%	1.05B
MARAVAI LIFESCIENCES HOLDINGS, INC.	-4.28%	-9.64%	+182.04%	-43.81%	866M
HANGZHOU ALLTEST BIOTECH CO., LTD.	+5.70%	+10.67%	-33.71%	+0.79%	572M
Average	+1.47%	+16.89%	+95.49%	+98.02%	1.94B
Weighted average by Cap.	+1.03%	+23.38%	+114.51%	+139.62%

Braster S.A. Stock

Stocks

BRA

PLBRSTR00014

Biotechnology & Medical Research

Valuation: Braster S.A.

Chart: Braster S.A.

Latest news : Braster S.A.

Course Extremes

Managers and Directors: Braster S.A.

Bio Diagnostics & Testing

Financials

Company Profile

Income Statement and Estimates

	2022	2023
Net sales	2.24M 601K 521K 488K 445K 837K 57.32M 851K 5.72M 28.69M 2.26M 2.21M 95.72M	319K 85.59K 74.17K 69.44K 63.36K 119K 8.16M 121K 814K 4.09M 321K 314K 13.63M
Net income	-3.87M -1.04M -900K -843K -769K -1.45M -99.09M -1.47M -9.88M -49.6M -3.9M -3.82M -165M	-4.75M -1.27M -1.1M -1.03M -943K -1.77M -122M -1.8M -12.12M -60.82M -4.78M -4.68M -203M
Net Debt	12.42M 3.33M 2.89M 2.7M 2.47M 4.64M 318M 4.72M 31.69M 159M 12.51M 12.24M 531M	11.3M 3.03M 2.63M 2.46M 2.24M 4.22M 289M 4.3M 28.85M 145M 11.39M 11.14M 483M